We collaborate with investigators from academia and industry to develop product development plans for early-stage drug therapy concepts.
TSRL, Inc. partners with academic researchers on SBIR/STTR grants in areas where our interests overlap. As experienced SBIR PIs, partnering with us offers several advantages to improve the overall chances of your project receiving an award, as well as maximizing its scope and duration. Due to these reasons we have obtained a higher-than-average success rate for funding awards over the last ten years.
Commercialization plan writing
Technology de-risking product development strategies
Wet lab space and AAALAC-accredited animal laboratories
Preliminary data generation
Types of Grants:
SBIR Phase I/II/III
Program grants (i.e. UO1)
RFAs (i.e. RO1 biodefense)
TSRL, Inc. has strong expertise in preclinical pharmacokinetic/dynamic (PK/PD), metabolism and biopharmaceutics studies designed to define human drug delivery strategies and dosing regimen.
Pharmacokinetic Studies in Rats and Mice
Preclinical Formulation Development
We conduct our research in a 7,200 sq. ft. facility of which 5,000 sq. ft. is wet lab space, with on-site analytical chemistry, formulation, cell culture equipment and capabilities. Office space and administrative support is also available.
Some of Our On-Site Equipment Includes:
Safety Cabinets & Fume Hoods
Computer Controlled Gradient LC/MS/MS Systems
Clinical and Micro Centrifuges
Liquid Handling Systems
Tissue Culture Incubators
Marketing and Business Development
As a part of our grant-writing process and commitment to maximizing commercial potential, TSRL Inc. will contribute resources on a per-project basis to business development and marketing. We have qualified professionals to establish a web presence for our partner companies. Likewise, we leverage our extensive networks to grow a stakeholder web around your technology, so it receives the support it needs to thrive.